glp 1 agonist anesthesia Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists glp 1 gastric emptying anesthesia
Description
While ertugliflozin did not outperform placebo for MACE, it significantly reduced hospitalizations for HF by 30% (59)
Furthermore, it suppressed food intake
"Consumers' overall high satisfaction with these medications for weight loss has been tempered primarily by concerns about side effects, weight gain if discontinued, and cost," said Kathy Risch, SVP, Shopper Insights and Thought Leadership, Acosta Group
Preliminary data show greater reductions in fasting glucose and HbA1c with a weekly injection
